Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LEVOTHYROXINE MANUFACTURERS HAVE THREE YEARS TO OBTAIN NDA APPROVAL UNDER FDA POLICY; AGENCY CITES POTENCY AND STABILITY PROBLEMS WITH THYROID PRODUCTS

Executive Summary

FDA is giving manufacturers of levothyroxine sodium three years to obtain NDA approval for their products under a new drug policy announced Aug. 14.

You may also be interested in...



Tighter Levothyroxine Standards Are Only First Step To Higher Quality – Cmte.

Tightening levothyroxine potency standards will not address underlying concerns about the quality of the manufacturing process for such products, members of the Endocrinologic & Metabolic Drugs and Pharmaceutical Science Advisory Committees said

Tighter Levothyroxine Standards Are Only First Step To Higher Quality – Cmte.

Tightening levothyroxine potency standards will not address underlying concerns about the quality of the manufacturing process for such products, members of the Endocrinologic & Metabolic Drugs and Pharmaceutical Science Advisory Committees said

Digoxin Timelines: Unapproved Tablets Can Remain 30 Days, Elixirs Two Years

Roxane Laboratories plans to submit an NDA for its digoxin elixir product in November, the company says

Related Content

UsernamePublicRestriction

Register

PS030695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel